Histogen Inc.
HSTOQ
$0.027
-$0.003-10.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 23.13% | -46.02% | |||
| Gross Profit | -23.35% | 46.26% | |||
| SG&A Expenses | 84.33% | -37.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 68.66% | -39.84% | |||
| Operating Income | -68.82% | 39.90% | |||
| Income Before Tax | -84.49% | 39.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -84.49% | 39.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 200.00% | -200.00% | |||
| Net Income | -84.08% | 39.71% | |||
| EBIT | -68.82% | 39.90% | |||
| EBITDA | -70.78% | 40.34% | |||
| EPS Basic | -84.09% | 39.71% | |||
| Normalized Basic EPS | -68.40% | 39.66% | |||
| EPS Diluted | -84.09% | 39.71% | |||
| Normalized Diluted EPS | -68.40% | 39.66% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||